Skip to main content
Gene therapy reduces pain, inflammation in dogs with osteoarthritis

An experimental gene therapy based on interleukin-10 is showing promise in dogs with severe osteoarthritis, reducing pain and inflammation and restoring their ability to move, and it could reduce the need for joint replacements in humans, says University of Colorado Boulder neuroscience professor Linda Watkins. More dogs are being accepted into clinical trials, and the FDA recently approved the experimental therapy for human use.

Full Story: